Building Quality by Design for Multi-Specific Therapeutic Proteins

Multi-specific therapeutic proteins are transforming the landscape of biologic drug development. Watch our expert, Dr. Rebecca Michael, presenting how integrating molecular design principles, platform analytics, and risk-based control strategies through a quality by design approach can streamline candidate selection, enhance manufacturability, and enable robust, scalable, and compliant development of multi-specific therapeutics from early discovery to clinical readiness. This session offers actionable insights to help you build quality into every stage of development.